Explore

Program Map

Start with a treatment, device, company, diagnosis, or trial ID. Each record keeps the source trail close to the claim.

161Main(26 active)

148Status checked

135Strong

320Backlog

More filters and sort (1 active)

Company-led only

1 records in Main database

Compare	Program	Company / Sponsor	Type	Product	Modality	Stage	Status	Reliability	Evidence	Conf.	Population	Indications	Inspect
Add	OHSU/Oricula ORC-13661 amikacin otoprotection study	Investigator-led studySponsor	Therapeutic	-	Small Molecule	Phase 2	Active	Details checkedClinical trial listing only	registry · Priority 2	83%	AdultOtotoxicity+3	Hearing LossOtotoxicity+1

Investigator-led study · Small Molecule · Phase 2

ActiveTherapeutic

Evidence

registry

Confidence

83%

Indications

Hearing LossOtotoxicityAminoglycoside-Induced Hearing Loss

Population

AdultOtotoxicityAmikacinNtm